A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B

Journal of Infection

Volumn 56, Issue 1, 2008, Pages 51-57

  Kawai, Naoki ^a   Ikematsu, Hideyuki ^a,b   Iwaki, Norio ^a   Maeda, Tetsunari ^a   Kanazawa, Hideo ^a   Kawashima, Takashi ^a   Tanaka, Osame ^a   Yamauchi, Satoshi ^a   Kawamura, Kenichi ^a   Nagai, Toru ^a   Horii, Satsuki ^a   Hirotsu, Nobuo ^a   Kashiwagi, Seizaburo ^c  

^a Japan Physician's Association   (Japan)

^b Hara Doi Hospital   (Japan)

^c Japanese Red Cross Kyushu Block Blood Center   (Japan)

Author keywords

Antigen detection test kits; Influenza; Oseltamivir; Virus isolation; Zanamivir

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; BODY TEMPERATURE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NONHUMAN; PERSISTENT VIRUS INFECTION; UNSPECIFIED SIDE EFFECT; VIRUS ISOLATION;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; FEMALE; FEVER; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; JAPAN; MALE; OSELTAMIVIR; TREATMENT OUTCOME; ZANAMIVIR;

EID: 37149003148     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.09.002     Document Type: Article

References (24)

1. Kawai N., Ikematsu H., Iwaki N., Satoh I., Kawashima T., Maeda T., et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Clin Infect Dis 40 (2005) 1309-1316
2. Kawai N., Ikematsu H., Iwaki N., Maeda T., Satoh I., Hirotsu N., et al. A Comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 43 (2006) 439-444
3. Kawai N., Ikematsu H., Iwaki N., Kawashima T., Maeda T., Mitsuoka S., et al. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect 55 (2007) 267-272
4. Sugaya N., Mitamura K., Yamazaki M., Tamura D., Ichikawa M., Kimura K., et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 44 (2007) 197-202
5. von Itzstein M., Wu W.Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363 (1993) 418-423
6. Hayden F.G., Osterhaus A.D., Treanor J.J., Fleming D.M., Aoki F.Y., Nicholson K.G., et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med 337 (1997) 874-880
7. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 352 (1998) 1877-1881
8. Mäkelä M.J., Pauksens K., Rostila T., Fleming D.M., Man C.Y., Keene O.N., et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect 40 (2000) 42-48
9. Kawai N., Ikematsu H., Iwaki N., Tanaka O., Yamanishi Y., Hirotsu N., et al. Zanamivir treatment is equally effective for both influenza A and influenza B. Clin Infect Dis 44 (2007) 1666
10. Noyola D.E., and Demmler G.J. Effect of rapid diagnosis on management of influenza A infections. Pediatr Infect Dis J 19 (2000) 303-307
11. Uyeki T.M. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 22 (2003) 164-177
12. Ikematsu H., Yamaji K., Fukuda T., Kawai N., Shigematsu T., Iwaki N., et al. Clinical evaluation of an immunochromatography test kit, Capilia Flu A, B, for rapid diagnosis of influenza. In: Kawaoka Y. (Ed). Options for control of influenza V (2004), Elsevier Science Publishers, Amsterdam, The Netherlands 372-375
13. Hara M., Takao S., Fukuda S., Shimazu Y., and Miyazaki K. Comparison of three rapid diagnostic kits using immunochromatography for detection of influenza A viruses (in Japanese). Kansenshogaku Zasshi 78 (2004) 935-941
14. Mitamura K., Yamazaki M., Ichikawa M., Kimura K., Kawakami C., Shimizu H., et al. Evaluation of an immunochromatography test using enzyme immunoassay for rapid detection of influenza A and B viruses (in Japanese). Kansenshogaku Zasshi 78 (2004) 597-603
15. Kubo N., Ikematsu H., Nabeshima S., Yamaji K., Nabeshima A., Kondou H., et al. Evaluation of an immunochromatography test kit for rapid diagnosis of influenza (in Japanese). Kansenshogaku Zasshi 77 (2003) 1007-1014
16. Hara M., Takao S., Fukuda S., Shimazu Y., Kuwayama M., Miyazaki K., et al. Comparison of four rapid diagnostic kits using immunochromatography to detect influenza B viruses. Kansenshogaku Zasshi 79 (2005) 803-811 [in Japanese]
17. Yamazaki M., Mitamura K., Ichikawa M., Kimura K., Komiyama O., Shimizu H., et al. Evaluation of flow-through immunoassay for rapid detection of influenza A and B viruses. Kansenshogaku Zasshi 78 (2004) 865-871 [in Japanese]
18. Kawai N., Ikematsu H., Iwaki N., Satoh I., Kawashima T., Tsuchimoto T., et al. A prospective, internet based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine 21 (2003) 4507-4513
19. Cass L.M., Brown J., Pickford M., Fayinka S., Newman S.P., Johansson C.J., et al. Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers. Clin Pharmacokinet 36 Suppl. 1 (1999) 21-31
20. Aoki F.Y., Macleod M.D., Paggiaro P., Carewicz O., El Sawy A., Wat C., et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrobial Chemother 51 (2003) 123-129
21. Gillissen A., and Hoffken G. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment. Med Microbiol Immunol 191 (2002) 165-168
22. Kaiser L., Fritz R.S., Straus S.E., Gubareva L., and Hayden F.G. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 64 (2001) 262-268
23. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol 74 (2000) 109-116
24. Hirotsu N., Ikematsu H., Iwaki N., Kawai N., Shigematsu T., Kunishima O., et al. Effects of antiviral drugs on viral detection in influenza patients and on the sequential infection to their family members. In: Kawaoka Y. (Ed). Options for control of influenza V (2004), Elsevier Science Publishers, Amsterdam, The Netherlands 105-108